Effect of eight-week online cognitive training in Parkinson's disease: A double-blind, randomized, controlled trial

被引:13
|
作者
van Balkom, Tim D. [1 ,2 ]
Berendse, Henk W. [3 ]
van der Werf, Ysbrand D. [2 ]
Twisk, Jos W. R. [4 ]
Peeters, Carel F. W. [5 ]
Hoogendoorn, Adriaan W. [6 ]
Hagen, Rob H. [7 ]
Berk, Tanja [7 ]
van den Heuvel, Odile A. [1 ,2 ]
Vriend, Chris [1 ,2 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam Neurosci, Psychiat, Amsterdam UMC, POB 7057, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam Neurosci, Anat & Neurosci, Amsterdam UMC, POB 7057, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Amsterdam Neurosci, Neurol, Amsterdam UMC, POB 7057, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Amsterdam Publ Hlth, Epidemiol & Biostat, Amsterdam UMC, POB 7057, Amsterdam, Netherlands
[5] Wageningen Univ & Res, Math & Stat Methods Grp Biometris, POB 16, NL-6700 AA Wageningen, Netherlands
[6] GGZ InGeest, Res & Innovat, Oldenaller 1, NL-1081 HL Amsterdam, Netherlands
[7] Dutch Parkinsons Dis Assoc, POB 46, NL-3980 CA Bunnik, Netherlands
关键词
Parkinson's disease; Cognitive training; RCT; Cognitive impairment; Dementia; Cognitive rehabilitation; DIAGNOSTIC-CRITERIA; IMPAIRMENT; DISORDER; DECLINE; BRAIN;
D O I
10.1016/j.parkreldis.2022.02.018
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Cognitive training (CT) has been proposed as a treatment option for cognitive impairment in Parkinson's disease (PD). We aimed to assess the efficacy of adaptive, computerized CT on cognitive function in PD. Methods: In this double-blind, randomized controlled trial we enrolled PD patients that experienced substantial subjective cognitive complaints. Over a period of eight weeks, participants underwent 24 sessions of computerized multi-domain CT or an active control intervention for 45 min each (randomized 1:1). The primary outcome was the accuracy on the Tower of London task; secondary outcomes included effects on other neuropsychological outcomes and subjective cognitive complaints. Outcomes were assessed before and after training and at six-months follow-up, and analyzed with multivariate mixed-model analyses. Results: The intention-to-treat population consisted of 136 participants (n = 68 vs. n = 68, age M: 62.9y, female: 39.7%). Multivariate mixed-model analyses showed no group difference on the Tower of London accuracy corrected for baseline performance (n = 130): B: 0.06, 95% CI: 0.27 to 0.15, p = 0.562. Participants in the CT group were on average 0.30 SD (i.e., 1.5 s) faster on difficulty load 4 of this task (secondary outcome): 95% CI: 0.55 to 0.06, p = 0.015. CT did not reduce subjective cognitive complaints. At follow-up, no group differences were found. Conclusions: This study shows no beneficial effect of eight-week computerized CT on the primary outcome (i.e., planning accuracy) and only minor improvements on secondary outcomes (i.e., processing speed) with limited clinical impact. Personalized or ecologically valid multi-modal intervention methods could be considered to achieve clinically meaningful and lasting effects.
引用
收藏
页码:80 / 87
页数:8
相关论文
共 50 条
  • [1] A double-blind randomized controlled trial of cognitive training for freezing of gait in Parkinson's disease
    Walton, C. C.
    Mowszowski, L.
    Shine, J. M.
    Gilat, M.
    Hall, J. M.
    O'Callaghan, C.
    Muller, A. J.
    Georiades, M.
    Szeto, J. Y. Y.
    Martens, K. A. Ehgoetz
    Naismith, S. L.
    Lewis, S. J. G.
    MOVEMENT DISORDERS, 2016, 31 : S694 - S695
  • [2] A double-blind, randomized controlled trial of duloxetine for pain in Parkinson's disease
    Iwaki, Hirotaka
    Ando, Rina
    Tada, Satoshi
    Nishikawa, Noriko
    Tsujii, Tomoaki
    Yamanishi, Yuki
    Miyaue, Noriyuki
    Yabe, Hayato
    Nagai, Masahiro
    Nomoto, Masahiro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 414
  • [3] COGTIPS: a double-blind randomized active controlled trial protocol to study the effect of home-based, online cognitive training on cognition and brain networks in Parkinson's disease
    van Balkom, Tim D.
    Berendse, Henk W.
    van der Werf, Ysbrand D.
    Twisk, Jos W. R.
    Zijlstra, Iris
    Hagen, Rob H.
    Berk, Tanja
    Vriend, Chris
    van den Heuvel, Odile A.
    BMC NEUROLOGY, 2019, 19 (1)
  • [4] COGTIPS: a double-blind randomized active controlled trial protocol to study the effect of home-based, online cognitive training on cognition and brain networks in Parkinson’s disease
    Tim D. van Balkom
    Henk W. Berendse
    Ysbrand D. van der Werf
    Jos W. R. Twisk
    Iris Zijlstra
    Rob H. Hagen
    Tanja Berk
    Chris Vriend
    Odile A. van den Heuvel
    BMC Neurology, 19
  • [5] Orlistat for the treatment of antipsychotic-induced weight gain: an eight-week multicenter, randomized, placebo-controlled, double-blind trial
    Xie, Peng
    Shao, Tiannan
    Long, Yujun
    Xie, Weiwei
    Liu, Yangjun
    Yang, Ye
    Huang, Yuyan
    Wu, Renrong
    Deng, Qijian
    Tang, Hui
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [6] A Randomized, Double-Blind, Placebo-Controlled Trial of Camicinal in Parkinson's Disease
    Marrinan, Sarah L.
    Otiker, Tal
    Vasist, Lakshmi S.
    Gibson, Rachel A.
    Sarai, Bhopinder K.
    Barton, Matthew E.
    Richards, Duncan B.
    Hellstrom, Per M.
    Nyholm, Dag
    Dukes, George E.
    Burn, David J.
    MOVEMENT DISORDERS, 2018, 33 (02) : 329 - 332
  • [7] Working on asymmetry in Parkinson's disease: A double-blind, randomized, controlled rehabilitation trial
    Ricciardi, L.
    Ricciardi, D.
    Lena, F.
    Petracca, M.
    Barricella, S.
    Modugno, N.
    Pelosin, E.
    Zuccala, G.
    Bentivoglio, A. R.
    Fasano, A.
    MOVEMENT DISORDERS, 2012, 27 : S135 - S136
  • [8] Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial
    Romo-Nava, Francisco
    Alvarez-Icaza Gonzalez, Deni
    Fresan-Orellana, Ana
    Saracco Alvarez, Ricardo
    Becerra-Palars, Claudia
    Moreno, Julia
    Ontiveros Uribe, Martha P.
    Berlanga, Carlos
    Heinze, Gerhard
    Buijs, Ruud M.
    BIPOLAR DISORDERS, 2014, 16 (04) : 410 - 421
  • [9] Ziprasidone versus risperidone in schizophrenia: An eight-week, double-blind trial with forty four-week continuation
    Benattia, I
    Addington, D
    Pantelis, C
    Dineen, M
    Murray, S
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 273 - 273
  • [10] Effects of ETyrosine on Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
    DiFrancisco-Donoghue, Joanne
    Rabin, Ely
    Lamberg, Eric M.
    Werner, William G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2014, 1 (04): : 348 - 353